Theravance News

News on Theravance (Ticker: THRX) continually updated from thousands of sources around the net.

Thursday May 24 | Reuters

Theravance licenses antibiotic tech to Hospira

Biopharmaceutical company Theravance Inc said it licensed its technology to manufacture antibiotic Vibativ to specialty medicines maker Hospira Inc.

Comment?

Related Topix: Startups, Television, Hispanic Broadcasting

Wed May 23, 2012

The Washington Post

Glaxo Avoids Market for Lemons by Acquiring Its Collaborators

GlaxoSmithKline Plc may find its next acquisition target where the U.K. drugmaker found the last two: among more than a dozen companies it collaborates with to develop new treatments.

Comment?

Seeking Alpha

GlaxoSmithKline: The Good News Just Keeps On Coming

Just last month GlaxoSmithKline was in the news for a move to acquire Human Genome Sciences , its partner of up to twenty years for $2.6 billion.

Comment?

Tue May 22, 2012

GlobeNewswire

Theravance to Present at Investor Conferences in June 2012

SOUTH SAN FRANCISCO, Calif., May 22, 2012 -- Theravance, Inc. announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at the following investor conferences in June 2012: All webcast information will be available on Theravance's web site at www.theravance.com . Listeners are encouraged to visit the site ... (more)

Comment?

Related Topix: Startups, Corporate / Securities Law, Law

Wed May 16, 2012

Drugs.com

GlaxoSmithKline Closes on Theravance Deal

British drug maker GlaxoSmithKline PLC has closed on a deal that boosts its interest in biotechnology company Theravance Inc.

Comment?